So a large-scale clinical trial is needed to assess whether GIK can reduce AMI mortality.

目前需要进行大规模试验评价GIK能否降低AMI病人死亡率。

Objective To evaluate the effects of high dose glucose-insulin-potassium (GIK) solution on hemodynamics in patients with acute myocardial infarction (ami).

目的评价高浓度极化液(GIK)对急性心肌梗死(ami)患者血液动力学的影响。

Meta analysis of all the clinical trials about GIK came to the conclusion that GIK had reduced AMI mortality by 18% that was only critical statistical significance.

对迄今所有的GIK临床试验荟萃分析显示GIK使AMI死亡率降低18%，仅有临界的统计学意义。

This result reveals that cardiovascular functions during acute hypoxia can be rapidly, markedly but temporarily improved when a small volume of GIK is administered intravenously.

结果提示：急性低氧时，GIK一次小量静注可迅速显著改善心血管功能。

AIM To investigate the preventive and therapeutic effects of GIK solution on high state of insulin and blood glucose, hormones and metabolic disorder in patients during cardiopulmonary bypass(CPB).

目的研究极化液（GIK）对体外循环后高胰岛素伴高血糖状态引起的内分泌和代谢紊乱的防治作用。

Objective To investigate the efficacy of magnesium in combination with glucose-insulin-potassium(Mg-GIK)in the treatment of arrhythmia, heart failure and mortality in acute myocardial infarction(AMI).

近年来，多次大规模临床试验和研究表明大剂量极化液（葡萄糖-胰岛素-钾，GIK）与心肌再灌注治疗联合应用能显著降低急性心肌梗死（AMI）患者的病死率。